Home/Adecto Pharmaceuticals/Gail E. Sonenshein, PhD

GE

Gail E. Sonenshein, PhD

Co-founder & President

Adecto Pharmaceuticals

Therapeutic Areas

Adecto Pharmaceuticals Pipeline

Drug	Indication	Phase
Anti-ADAM8 mAb	ADAM8-positive cancers (e.g., Colorectal, Breast, Kidney)	Pre-clinical

Leadership Team at Adecto Pharmaceuticals

Nora D. Mineva, PhD

Co-founder, CEO & Chief Scientific Officer

Stefania Pianetti, PhD

Head, Preclinical & Translational Development

John Tagliamonte, MBA

Corporate Development Lead

View full Adecto Pharmaceuticals profile